Evidence map›Paper›PMID 23366288›Full record

Trial reportAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2012

Towards the use of a lower limb exoskeleton for locomotion assistance in individuals with neuromuscular locomotor deficits.

Spencer Murray, Michael Goldfarb

Abstract readClinical Trial
In one paragraph

Trial report in Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Overground Walking With a Transparent Exoskeleton Shows Changes in Spatiotemporal Gait Parameters.IEEE journal of translational engineering in health and medicine · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Spencer MurrayVanderbilt University, Nashville, TN 37235, USA. spencer.a.murray@vanderbilt.edu
Michael Goldfarb

Funding

A Joint-Coupled Controlled-Brake Orthosis System for Hybrid FES Gait RestorationR01HD059832 · NICHD · VANDERBILT UNIVERSITY · PI GOLDFARB, MICHAEL · 2009 to 2013
$1.9M
NICHD NIH HHS 1R01HD059832-01A1NICHD NIH HHS R01 HD059832
6 · The paper itself

Abstract

The authors intend to utilize a lower limb exoskeleton for gait assistance in individuals with lower limb neuromuscular deficit. The authors suggest that two foundational elements are required to do so effectively. First, the exoskeleton system must be capable of reliable real-time gait phase detection, in order to determine the nature of gait assistance to provide. Second, in gait phases or circumstances in which the exoskeleton provides minimal assistance, the passive dynamics of the exoskeleton should not hinder the individual (i.e., should have the capability to minimally interfere with gait dynamics). As such, the exoskeleton system should be capable of actively compensating for its passive dynamics, namely the inertial, gravitational, and frictional effects it imposes on the user. This paper describes the implementation of these two foundational elements (real-time gait phase detection and active cancellation of passive dynamics) on a prototype lower limb exoskeleton, and provides experimental data demonstrating their respective efficacy.

Indexed as

Orthotic DevicesAdultBiomechanical PhenomenaElectromyographyGaitHipHumansKneeLocomotionLower ExtremityNeuromuscular DiseasesRange of Motion, ArticularYoung Adult

Identifiers

PMID23366288
PMCPMC3688043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.